Is there still a benefit to operate appendiceal abscess on board French nuclear submarines?

Mil Med. 2009 Aug;174(8):874-7. doi: 10.7205/milmed-d-00-1509.

Abstract

Appendicular abscess occurred in 14.2% of patients presenting acute appendicitis. Management of these patients remains controversial, ranging from an emergency appendectomy to a nonoperative treatment. On board French nuclear submarines, the usual treatment for all cases of appendiceal masses, including both appendicitis and appendiceal abscess, is an appendectomy. In the past 5 years, the introduction of ultrasonography (US) on board has enabled the diagnosis of appendiceal abscess with a high rate of accuracy, and the latest studies show that nonoperative treatment is an alternative approach. This nonsurgical treatment, based on intravenous administration of antibiotics, is successful in about 93% of the patients. Failure of nonsurgical treatment is a reliable indication of percutaneous drainage. The proportion of adult patients who need percutaneous drainage of abscesses is about 27%. A successful primary nonoperative treatment may or may not be followed by interval appendectomy at the conclusion of the patrol. Nonsurgical treatment is associated with a significantly lower morbidity than surgery. Considering that the on-board surgical facility is limited, nonsurgical treatment appears to be the best approach for treating a sailor with an appendiceal abscess during a submarine patrol mission.

Publication types

  • Case Reports

MeSH terms

  • Abscess / diagnostic imaging
  • Abscess / etiology
  • Abscess / surgery*
  • Adult
  • Anti-Bacterial Agents / therapeutic use
  • Appendicitis / diagnostic imaging
  • Appendicitis / drug therapy
  • Appendicitis / microbiology
  • Appendicitis / surgery*
  • Appendix / surgery*
  • Carbapenems / therapeutic use
  • France
  • Humans
  • Male
  • Military Personnel*
  • Pasteurella
  • Rupture / diagnostic imaging
  • Rupture / surgery
  • Submarine Medicine*
  • Ultrasonography

Substances

  • Anti-Bacterial Agents
  • Carbapenems